줄기세포 치료 시장 규모, 점유율, 동향 분석 보고서 : 치료 유형별, 치료 용도별, 지역별, 부문별 예측(2025-2030년)

Stem Cell Therapy Market Growth & Trends:

The global stem cell therapy market size is estimated to reach at USD 1,670.1 million in 2030 and is expected to grow at a CAGR of 25.23% from 2025 to 2030. The market growth is propelled by several key factors that underscore both scientific advancements and evolving healthcare needs.Advancements in stem cell research and technology have revolutionized the landscape of regenerative medicine. Breakthroughs in stem cell isolation, characterization, and manipulation techniques have empowered researchers to harness the therapeutic potential of stem cells with greater precision and efficacy. For instance, in May 2023, EPROCELL introduced Contract Development and Manufacturing Organization (CDMO) services for producing Advanced Therapies Medicinal Products (ATMPs) derived from mesenchymal stem cells (MSC). This expansion is facilitated by a partnership with Histocell. These advancements have spurred the development of innovative therapies targeting a wide spectrum of medical conditions, from chronic diseases to degenerative disorders.

The increasing prevalence of chronic and degenerative diseases has fueled the demand for novel treatment modalities. Conditions such as cardiovascular diseases, neurodegenerative disorders, orthopedic injuries, and autoimmune diseases pose significant healthcare challenges, driving the search for innovative therapeutic approaches. For instance, a study published in The Lancet Neurology has anticipated a significant increase in the number of individuals affected by Parkinson's disease by the year 2040. The projected figure is alarming, as it suggests that the number of people living with this neurodegenerative disorder may double, reaching at least 12.9 million worldwide. Stem cell therapies hold immense promise in addressing these complex diseases by promoting tissue regeneration, modulating immune responses, and restoring organ function, thus offering new avenues for disease management and treatment.

Investment in the global market has been steadily increasing as investors recognize the potential for groundbreaking medical advancements and lucrative returns. This influx of capital fuels research, development, and commercialization efforts, driving the overall market growth. With a growing emphasis on regenerative medicine and personalized healthcare, the market is poised for continued expansion, offering innovative treatments and renewed hope to patients grappling with a wide range of medical conditions.

Stem Cell Therapy Market Report Highlights:

• Based on the therapy type, the market is segmented into allogeneic stem cell therapy and autologous stem cell therapy. The allogeneic stem cell therapies segment dominated the market with a share of 69.22% in 2024.
• The autologous stem cell therapy market is witnessing a significant expansion, driven by significant progress in clinical trials and research within the field.
• Based on therapeutic application, the market is segmented into oncology, cardiovascular disease (CVD), musculoskeletal disorders, and others. The others segment accounted for 72.45% in 2024, fueled by ongoing research and clinical advancements.
• North America accounted for the largest market share of 50.67% in 2024 and the highest CAGR during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Therapy Type
  • 1.2.2. Therapeutic Application
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing research & development in stem cell therapy
    • 3.2.1.2. Increasing prevalence of chronic diseases
    • 3.2.1.3. Technological advancements
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of stem cell therapy
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Stem Cell Therapy Market: Therapy Type Business Analysis

• 4.1. Segment Dashboard
• 4.2. Global Stem Cell Therapy Market Therapy Type Movement Analysis
• 4.3. Global Stem Cell Therapy Market Size & Trend Analysis, by Therapy Type, 2018 to 2030 (USD Million)
• 4.4. Allogeneic Stem Cell Therapies
  • 4.4.1. Global Allogeneic Stem Cell Therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Hematopoietic Stem Cell Therapies
    • 4.4.2.1. Global Hematopoietic Stem Cell Therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Mesenchymal Stem Cell Therapies
    • 4.4.3.1. Global Mesenchymal Stem Cell Therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Autologous Stem Cell Therapies by Type
  • 4.5.1. Global Autologous Stem Cell Therapies, by Type Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. BM, Blood, & Umbilical Cord-derived Stem Cells
    • 4.5.2.1. Global BM, Blood, & Umbilical Cord-derived Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Adipose-Derived Cells
    • 4.5.3.1. Global Adipose-Derived Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Others
    • 4.5.4.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Stem Cell Therapy Market: Therapeutic Application Business Analysis

• 5.1. Segment Dashboard
• 5.2. Global Stem Cell Therapy Market Therapeutic Application, Movement Analysis
• 5.3. Global Stem Cell Therapy Market Size & Trend Analysis by Therapeutic Application, 2018 to 2030 (USD Million)
• 5.4. Oncology
  • 5.4.1. Global Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Cardiovascular Disease (CVD)
  • 5.5.1. Global Cardiovascular Disease (CVD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Musculoskeletal Disorders
  • 5.6.1. Global Musculoskeletal Disorders Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Stem Cell Therapy Market: Regional Estimates & Trend Analysis by Therapy Type, and Therapeutic Application

• 6.1. Regional Dashboard
• 6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 6.3. North America
  • 6.3.1. North America Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. U.S.
    • 6.3.2.1. Key Country Dynamics
    • 6.3.2.2. Competitive Scenario
    • 6.3.2.3. Regulatory Framework
    • 6.3.2.4. U.S. Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Canada
    • 6.3.3.1. Key Country Dynamics
    • 6.3.3.2. Competitive Scenario
    • 6.3.3.3. Regulatory Framework
    • 6.3.3.4. Canada Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Europe
  • 6.4.1. Europe Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. UK
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Competitive Scenario
    • 6.4.2.3. Regulatory Framework
    • 6.4.2.4. UK Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Germany
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Competitive Scenario
    • 6.4.3.3. Regulatory Framework
    • 6.4.3.4. Germany Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. Switzerland
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Competitive Scenario
    • 6.4.4.3. Regulatory Framework
    • 6.4.4.4. Switzerland Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Asia Pacific Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Japan
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Japan Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. China
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. China Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. India
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. India Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. South Korea
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Competitive Scenario
    • 6.5.5.3. Regulatory Framework
    • 6.5.5.4. South Korea Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Rest of World
  • 6.6.1. Rest of World Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2024
• 7.4. Participant's Overview
  • 7.4.1. Bluebird Bio, Inc.
    • 7.4.1.1. Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. NIPRO
    • 7.4.2.1. Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. Kyowa Kirin
    • 7.4.3.1. Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. Pharmicell Co., Ltd.
    • 7.4.4.1. Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Strategic Initiatives
  • 7.4.5. CorestemChemon Inc.
    • 7.4.5.1. Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Strategic Initiatives
  • 7.4.6. ANTEROGEN.CO.,LTD.
    • 7.4.6.1. Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. Holostem S.r.l.
    • 7.4.7.1. Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. Vertex Pharmaceuticals, Inc.
    • 7.4.8.1. Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Strategic Initiatives
  • 7.4.9. Cleveland Cord Blood Center
    • 7.4.9.1. Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Strategic Initiatives
  • 7.4.10. Highbridge Capital Management
    • 7.4.10.1. Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Strategic Initiatives